The BPRC has led multiple national and international proteomics projects. The Chinese Human Liver Proteome Project (CNHLPP) is one of them. CNHLPP is an ambitious project that aims to construct a human liver proteome reference map by cataloguing protein expression, modification and protein-protein interaction in the liver. The reference map will serve as a starting point for the systems biology view of liver physiology and pathology and lay the foundation for understanding and eventually curing the liver diseases.
The largest dataset of a human organ proteome, the first version of the human liver proteome (HLP), has been established by the Chinese Human Liver Proteome Profiling Consortium. This dataset comprises of 6788 proteins each with at least two peptides that are identified at 5% false discovery rate.
SPECIAL TOPIC
Concurrently, they obtained the human liver transcriptome (HLT) dataset using the same sample, which consists of 11205 transcripts. They found direct association between HLT and HLP. Preliminary analysis of HLP revealed that proteins involved in liver-specific functions, such as bile transport, bile acid synthesis, and bilirubin metabolism, are well represented as expected; proteins involved in metabolism, nutrient transport, and blood coagulation, as well as complement systems comprise the majority of HLP. MAP kinases and signaling components in calcium, adhesion, insulin, and adipocytokine actions are identified. Half of the HLP are discovered in liver for the first time, and 82.5% of them are of low abundance. For example, four members of the cytochrome P450 family and three ion channels are described for the first time in liver. The overlap in coagulation, anticoagulation, fibrinolysis, and complement system between human liver and plasma proteomes is particularly noteworthy, demonstrating a significant positive correlation between the abundance of coagulator proteins in liver and plasma. The success of the human liver proteome project will have a high impact on the understanding of liver diseases such as non-alcoholic steatohepatitis (or NASH), HBV infection, and hepatic cancers. The dataset of human liver proteome has built a solid foundation for future identification of new biomarkers and targets of therapeutic intervention in liver diseases.
The Center has also developed a protein-protein interaction map and has comprehensively compared the protein expression patterns of human fetal liver samples from different development stages with intriguingly different physiological characteristics. This dataset represents the first comprehensive description of the human liver protein interaction network. They utilized the high-throughput yeast two-hybrid technology to map the interactions of 5026 human liver proteins. A network of 3484 interactions amongst 2582 proteins was established and 72% of them were validated with three independent assays.
The biological significance of this interaction network has been illustrated by the topological analyses of metabolic enzymes, liver-specific and liver-disease proteins, as well as their associated proteins. Of those analyzed, 166 proteins are expected to cause a liver phenotype if their function is disrupted and 58 proteins are potential liver-disease candidates. This dataset will help to obtain a system biology outlook of protein interactions in human liver cancer cells. Such information will transform the field of basic biology research in liver function and impact all biological research where protein interactions play a regulatory role.
To facilitate the use of the valuable resources and make them accessible to the wider scientific community, we have made available publicly databases such as dbLEP (http:// dblep.hupo.org.cn), liverbase (http://liverbase.hupo.org.cn) and livermap (http://livermap.hupo.org.cn). The Center has accumulated a large volume of primary biological information and has begun to appreciate the complexicity of the liver proteome.
To provide unparalleled capacity for proteomics in the next five to ten years, they are building a large national scientific facility for proteomics, dubbed Pilot Hub of ENcyclopedical proteomIX (PHOENIX). The PHOENIX project is the first specialized facility for life sciences of its kind among Chinese national large scientific facilities and is headed by BPRC. It will host most of the large modern instruments for protein science with mass spectrometry, optical molecular imaging, cryo-electron microscopy (Cryo-EM), and nuclear magnetic resonance (NMR). If such progress continues, it will not be long before we find 'proteomics' appearing regularly in the language of popular science.
I hope this special issue--At a glance: Proteomics in China will stimulate your interest in Chinese proteomics. Enjoy the special issue that includes eight papers representing a broader overview of proteomics in China.
Thank you very much.
